You just read:

Audentes Therapeutics Announces Commencement of LUSTRO, a Clinical Assessment and Phase 1/2 Run-in Study of Patients with Crigler-Najjar Syndrome

News provided by

Audentes Therapeutics, Inc.

Mar 01, 2017, 08:00 ET